PUBLIC CONTRACT · 2023
Antimetabolitos - Azacitidina, cladribina e pemetrexedo - 1o semestre
- Contract value
- €3,571.75
- Signed on
- 13 April 2023
- Procedure
- Prior consultation (Consulta Prévia)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 9926219PUBLISHED SUBJECT
ANTIMETABOLITOS - AZACITIDINA, CLADRIBINA E PEMETREXEDO - 1o SEMESTRE
WHO CONTRACTED
Parties involved
- Place of performance
- Portugal, Região Autónoma da Madeira, Funchal
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- SANDOZ FARMACÊUTICA, LDA. · Tax ID 506985261
HOW MUCH AND WHEN
Values and timeline
- Contract price
- €3,571.75
- Procedure base price
- €78,808.39
- Total effective price
- €3,571.75
- Publication date
- 13 April 2023
- Award date
- 11 April 2023
- Signing date
- 13 April 2023
- Performance period
- 122 days
The contract price is the value agreed in the contract, not the amount paid.
HOW IT WAS CONTRACTED
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Prior consultation (Consulta Prévia)
- Award criterion
- Monofator
- CPV code
- 33690000-3 - Medicamentos vários
- Legal basis
- Artigo 259.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL 111-B/2017) e Lei n.º 30/2021, de 21.05 e DLR no 34/2008/M, de 14.08 (DLR n.º 6/2018/M)
- Framework agreement
- Not stated
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 6325207
KEEP EXPLORING
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.